How blood clots and medications affect peripheral artery disease
The Impact of Thrombosis and Antithrombotic Therapy on Peripheral Artery Disease
['FUNDING_OTHER'] · VANDERBILT UNIVERSITY MEDICAL CENTER · NIH-11021052
This study is looking at how blood clots and certain medications might affect the development of peripheral artery disease (PAD), and it aims to find better treatment options for patients like you.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | VANDERBILT UNIVERSITY MEDICAL CENTER (nih funded) |
| Locations | 1 site (NASHVILLE, UNITED STATES) |
| Trial ID | NIH-11021052 on ClinicalTrials.gov |
What this research studies
This research investigates the role of blood clots and antithrombotic medications in the development of peripheral artery disease (PAD). The study aims to understand the biological pathways involved in PAD by examining how thrombotic mechanisms contribute to the condition. Patients may benefit from insights gained through this research, which could lead to improved treatment strategies. The research will utilize advanced methodologies, including Mendelian randomization, to quantify risks associated with thrombotic pathways.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with peripheral artery disease or those at high risk for developing it.
Not a fit: Patients without peripheral artery disease or those not at risk for cardiovascular conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better treatment options for patients with peripheral artery disease.
How similar studies have performed: Previous research has shown promising results in understanding thrombotic mechanisms in cardiovascular diseases, suggesting potential for success in this area.
Where this research is happening
NASHVILLE, UNITED STATES
- VANDERBILT UNIVERSITY MEDICAL CENTER — NASHVILLE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: ADAY, AARON W. — VANDERBILT UNIVERSITY MEDICAL CENTER
- Study coordinator: ADAY, AARON W.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.